(Q35876328)

10 August 2017

1 reference

title

Antiviral therapy for influenza : a clinical and economic comparative review (English)

1 reference

10 August 2017

Alexander C Schmidt

1

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

64

1 reference

10 August 2017

issue

18

1 reference

10 August 2017

page(s)

2031-2046

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464180-00003

10 August 2017

exact match

0 references

cites work

Oseltamivir: a review of its use in influenza

1 reference

12 December 2020

Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2).

1 reference

12 December 2020

Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group

1 reference

12 December 2020

Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines

1 reference

12 December 2020

Study of rimantadine in the USSR: a review of the literature

1 reference

12 December 2020

The predictive value of influenza symptomatology in elderly people

1 reference

12 December 2020

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

1 reference

12 December 2020

The management of influenza in people of working age.

1 reference

12 December 2020

Economic analysis of influenza vaccination and antiviral treatment for healthy working adults

1 reference

12 December 2020

Adverse reactions to amantadine prophylaxis of influenza in a retirement home

1 reference

12 December 2020

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

1 reference

12 December 2020

The molecular basis of the specific anti-influenza action of amantadine

1 reference

12 December 2020

Perspectives on antiviral use during pandemic influenza

1 reference

12 December 2020

Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis

1 reference

12 December 2020

Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults

1 reference

12 December 2020

Zanamivir: a review of its use in influenza

1 reference

12 December 2020

Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block

1 reference

12 December 2020

Antiviral therapy of influenza

1 reference

12 December 2020

Effect of rimantadine treatment on clinical manifestations and otologic complications in adults experimentally infected with influenza A (H1N1) virus

1 reference

12 December 2020

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

1 reference

12 December 2020

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

1 reference

12 December 2020

Oral oseltamivir treatment of influenza in children.

1 reference

12 December 2020

Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza

1 reference

12 December 2020

Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center

1 reference

12 December 2020

Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine

1 reference

12 December 2020

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

1 reference

12 December 2020

Influenza-associated morbidity and mortality in young and middle-aged women

1 reference

12 December 2020

Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial.

1 reference

12 December 2020

A comparison of acetaminophen and rimantadine in the treatment of influenza A infection in children

1 reference

12 December 2020

Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study

1 reference

12 December 2020

Influenza A virus outbreak in a neonatal intensive care unit

1 reference

12 December 2020

Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults

1 reference

12 December 2020

Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral Therapy

1 reference

12 December 2020

Oseltamivir for treatment of influenza in healthy adults: pooled trial evidence and cost-effectiveness model for Canada

1 reference

12 December 2020

Children with influenza A infection: treatment with rimantadine.

1 reference

12 December 2020

Early administration of oral oseltamivir increases the benefits of influenza treatment

1 reference

12 December 2020

Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults

1 reference

12 December 2020

The impact of influenza epidemics on mortality: introducing a severity index.

1 reference

12 December 2020

Cost effectiveness of zanamivir for the treatment of influenza in a high risk population in Australia

1 reference

12 December 2020

Cost-effectiveness of newer treatment strategies for influenza

1 reference

12 December 2020

Treatment and prevention of influenza: Swedish recommendations

1 reference

12 December 2020

Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials

1 reference

12 December 2020

The impact of influenza epidemics on hospitalizations.

1 reference

12 December 2020

Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients

1 reference

12 December 2020

High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza

1 reference

12 December 2020

Why do older people not get immunised against influenza? A community survey

1 reference

12 December 2020

Influenza virus neuraminidase inhibitors

1 reference

12 December 2020

Amantadine kinetics in healthy elderly men: implications for influenza prevention

1 reference

12 December 2020

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Influenza. Cost of illness and considerations in the economic evaluation of new and emerging therapies

1 reference

12 December 2020

Successful treatment of naturally occurring influenza A/USSR/77 H1N1.

1 reference

12 December 2020

Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance

1 reference

12 December 2020

Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates.

1 reference

12 December 2020

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

12 December 2020

Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza

1 reference

12 December 2020

Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man.

1 reference

12 December 2020

Predicting influenza infections during epidemics with use of a clinical case definition

1 reference

12 December 2020

10.2165/00003495-200464180-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1020523011

0 references

Fatcat ID

release_cdzy3ciwwzgpviigyu4orvjwga

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cdzy3ciwwzgpviigyu4orvjwga

24 November 2022

mapped directly with Wikidata item

1 reference